Affordable Access

Publisher Website

Correct laboratory approach to APS diagnosis and monitoring

Authors
Journal
Autoimmunity Reviews
1568-9972
Publisher
Elsevier
Volume
12
Issue
8
Identifiers
DOI: 10.1016/j.autrev.2012.11.008
Keywords
  • Thrombosis
  • Antiphospholipid Syndrome
  • Lupus Anticoagulant

Abstract

Abstract Triple positivity (positive Lupus Anticoagulant, anticardiolipin and anti β2-glycoptrotein I antibodies) identifies the pathogenic autoantibody (anti Domain I of β2-glycoptroteinI) that is present in patients with definite Antiphospholipid Syndrome (APS). This is supported by the fact that aβ2GPI antibodies obtained by affinity purification in these patients possess LA activity. Moreover, patients and carriers of this profile carry a much higher risk of thrombosis and pregnancy loss than APS patients with positivity for only one of the tests. Thus, very different risk categories exist among patients with APS as well as among carriers of aPL. Clinical studies and interventional trials should first take these high risk subjects into consideration.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Prevention of in vitro fibrinogenolysis during lab...

on Blood coagulation & fibrinolys... April 1991

A problem-oriented approach to laboratory diagnosi...

on The Veterinary clinics of Nort... November 1976

New approach to laboratory diagnosis.

on Africa health November 1997

Diagnosis of HIV infection and laboratory monitori...

on Journal of Clinical Virology June 2001
More articles like this..